Related references
Note: Only part of the references are listed.The Antibacterial Research and Development Pipeline Needs Urgent Solutions
Peter Beyer et al.
ACS INFECTIOUS DISEASES (2020)
A Review of the Clinical Pharmacokinetics of Polymyxin B
Sean N. Avedissian et al.
ANTIBIOTICS-BASEL (2019)
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Alexandre P. Zavascki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Role of Renal Drug Exposure in Polymyxin B-Induced Nephrotoxicity
Pooja Manchandani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B
Ziyue Li et al.
MEDICINE (2016)
Epidemiology of antimicrobial resistance in bloodstream infections
Murat Akova
VIRULENCE (2016)
Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes
Venkata. S. Sabbisetti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Imperfect gold standards for biomarker evaluation
Sushrut S. Waikar et al.
CLINICAL TRIALS (2013)
Characterization of Polymyxin B-Induced Nephrotoxicity: Implications for Dosing Regimen Design
Kamilia Abdelraouf et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
Lesley A. Inker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Next-generation biomarkers for detecting kidney toxicity
Joseph V. Bonventre et al.
NATURE BIOTECHNOLOGY (2010)
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
Frank Dieterle et al.
NATURE BIOTECHNOLOGY (2010)
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
R Bellomo et al.
CRITICAL CARE (2004)
Share Paper
